Annual D&A
$15.18 M
+$153.00 K+1.02%
31 December 2023
Summary:
Standard BioTools annual depreciation & amortization is currently $15.18 million, with the most recent change of +$153.00 thousand (+1.02%) on 31 December 2023. During the last 3 years, it has fallen by -$391.00 thousand (-2.51%). LAB annual D&A is now -18.43% below its all-time high of $18.61 million, reached on 01 December 2017.LAB Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$3.86 M
+$2000.00+0.05%
30 September 2024
Summary:
Standard BioTools quarterly depreciation & amortization is currently $3.86 million, with the most recent change of +$2000.00 (+0.05%) on 30 September 2024. Over the past year, it has dropped by -$48.00 thousand (-1.23%). LAB quarterly D&A is now -25.72% below its all-time high of $5.19 million, reached on 31 March 2024.LAB Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$16.81 M
-$128.00 K-0.76%
30 September 2024
Summary:
Standard BioTools TTM depreciation & amortization is currently $16.81 million, with the most recent change of -$128.00 thousand (-0.76%) on 30 September 2024. Over the past year, it has increased by +$1.63 million (+10.76%). LAB TTM D&A is now -10.47% below its all-time high of $18.78 million, reached on 01 June 2017.LAB TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LAB Depreciation And Amortization Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | -1.2% | +10.8% |
3 y3 years | -2.5% | -0.6% | +8.0% |
5 y5 years | -4.0% | -1.6% | +6.4% |
LAB Depreciation And Amortization High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -4.7% | +1.0% | -25.7% | +7.1% | -0.8% | +15.9% |
5 y | 5 years | -8.4% | +1.0% | -25.7% | +7.1% | -0.8% | +15.9% |
alltime | all time | -18.4% | +1231.6% | -25.7% | >+9999.0% | -10.5% | +4051.6% |
Standard BioTools Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $3.86 M(+0.1%) | $16.81 M(-0.8%) |
June 2024 | - | $3.86 M(-25.8%) | $16.94 M(+1.4%) |
Mar 2024 | - | $5.19 M(+33.0%) | $16.71 M(+10.1%) |
Dec 2023 | $15.18 M(+1.0%) | $3.91 M(-2.0%) | $15.18 M(+1.9%) |
Sept 2023 | - | $3.99 M(+9.9%) | $14.89 M(+2.6%) |
June 2023 | - | $3.63 M(-1.0%) | $14.51 M(-1.4%) |
Mar 2023 | - | $3.66 M(+1.2%) | $14.72 M(-2.1%) |
Dec 2022 | $15.03 M(-3.5%) | $3.62 M(+0.5%) | $15.03 M(-1.7%) |
Sept 2022 | - | $3.60 M(-6.1%) | $15.29 M(-1.7%) |
June 2022 | - | $3.83 M(-3.4%) | $15.56 M(-0.4%) |
Mar 2022 | - | $3.97 M(+2.3%) | $15.63 M(+0.3%) |
Dec 2021 | $15.57 M(-2.2%) | $3.88 M(+0.3%) | $15.57 M(-0.8%) |
Sept 2021 | - | $3.87 M(-0.7%) | $15.70 M(-0.6%) |
June 2021 | - | $3.90 M(-0.5%) | $15.79 M(+0.0%) |
Mar 2021 | - | $3.92 M(-2.2%) | $15.78 M(-0.9%) |
Dec 2020 | $15.92 M(+0.8%) | - | - |
Dec 2020 | - | $4.01 M(+1.1%) | $15.92 M(+0.5%) |
Sept 2020 | - | $3.96 M(+1.9%) | $15.84 M(+0.2%) |
June 2020 | - | $3.89 M(-4.1%) | $15.81 M(-0.4%) |
Mar 2020 | - | $4.06 M(+3.5%) | $15.87 M(+0.4%) |
Dec 2019 | $15.80 M(-4.6%) | - | - |
Dec 2019 | - | $3.92 M(-0.3%) | $15.80 M(-0.8%) |
Sept 2019 | - | $3.93 M(-0.7%) | $15.93 M(-0.4%) |
June 2019 | - | $3.96 M(-0.8%) | $15.99 M(+1.3%) |
Mar 2019 | - | $3.99 M(-1.4%) | $15.78 M(-4.8%) |
Dec 2018 | $16.57 M(-10.9%) | $4.05 M(+1.5%) | $16.57 M(-3.4%) |
Sept 2018 | - | $3.99 M(+6.5%) | $17.15 M(-1.7%) |
June 2018 | - | $3.75 M(-21.6%) | $17.45 M(-6.4%) |
Mar 2018 | - | $4.78 M(+3.3%) | $18.64 M(+0.2%) |
Dec 2017 | $18.61 M | $4.63 M(+7.9%) | $18.61 M(+0.4%) |
Sept 2017 | - | $4.29 M(-13.1%) | $18.54 M(-1.3%) |
June 2017 | - | $4.94 M(+3.9%) | $18.78 M(+2.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2017 | - | $4.75 M(+4.1%) | $18.32 M(+2.2%) |
Dec 2016 | $17.94 M(+11.3%) | $4.57 M(+0.9%) | $17.94 M(+5.2%) |
Sept 2016 | - | $4.53 M(+1.0%) | $17.06 M(+2.9%) |
June 2016 | - | $4.48 M(+2.6%) | $16.58 M(+1.5%) |
Mar 2016 | - | $4.37 M(+18.5%) | $16.34 M(+1.4%) |
Dec 2015 | $16.11 M(+16.3%) | $3.69 M(-9.0%) | $16.11 M(-1.6%) |
Sept 2015 | - | $4.05 M(-4.5%) | $16.37 M(+1.1%) |
June 2015 | - | $4.24 M(+2.5%) | $16.20 M(+3.3%) |
Mar 2015 | - | $4.14 M(+5.1%) | $15.68 M(+13.1%) |
Dec 2014 | $13.86 M(+443.4%) | $3.94 M(+1.5%) | $13.86 M(+30.5%) |
Sept 2014 | - | $3.88 M(+4.2%) | $10.62 M(+43.6%) |
June 2014 | - | $3.72 M(+60.4%) | $7.40 M(+72.6%) |
Mar 2014 | - | $2.32 M(+231.0%) | $4.29 M(+68.1%) |
Dec 2013 | $2.55 M(+16.4%) | $701.00 K(+6.7%) | $2.55 M(+4.2%) |
Sept 2013 | - | $657.00 K(+7.9%) | $2.45 M(+5.3%) |
June 2013 | - | $609.00 K(+4.3%) | $2.33 M(+2.0%) |
Mar 2013 | - | $584.00 K(-2.5%) | $2.28 M(+4.1%) |
Dec 2012 | $2.19 M(+55.4%) | $599.00 K(+12.4%) | $2.19 M(-2.4%) |
Sept 2012 | - | $533.00 K(-5.5%) | $2.25 M(+14.2%) |
June 2012 | - | $564.00 K(+13.9%) | $1.97 M(+19.7%) |
Mar 2012 | - | $495.00 K(-24.3%) | $1.64 M(+16.5%) |
Dec 2011 | $1.41 M(+23.7%) | $654.00 K(+158.5%) | $1.41 M(+92.6%) |
Sept 2011 | - | $253.00 K(+5.4%) | $732.00 K(-27.6%) |
June 2011 | - | $240.00 K(-8.7%) | $1.01 M(+1.3%) |
Mar 2011 | - | $263.00 K(-1195.8%) | $998.00 K(-12.5%) |
Dec 2010 | $1.14 M(-41.2%) | -$24.00 K(-104.5%) | $1.14 M(-2.1%) |
Sept 2010 | - | $532.00 K(+134.4%) | $1.16 M(+84.2%) |
June 2010 | - | $227.00 K(-44.0%) | $632.00 K(+56.0%) |
Mar 2010 | - | $405.00 K | $405.00 K |
Dec 2009 | $1.94 M(-1.4%) | - | - |
Dec 2008 | $1.97 M(-8.0%) | - | - |
Dec 2007 | $2.14 M(+46.5%) | - | - |
Dec 2006 | $1.46 M | - | - |
FAQ
- What is Standard BioTools annual depreciation & amortization?
- What is the all time high annual D&A for Standard BioTools?
- What is Standard BioTools quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Standard BioTools?
- What is Standard BioTools quarterly D&A year-on-year change?
- What is Standard BioTools TTM depreciation & amortization?
- What is the all time high TTM D&A for Standard BioTools?
- What is Standard BioTools TTM D&A year-on-year change?
What is Standard BioTools annual depreciation & amortization?
The current annual D&A of LAB is $15.18 M
What is the all time high annual D&A for Standard BioTools?
Standard BioTools all-time high annual depreciation & amortization is $18.61 M
What is Standard BioTools quarterly depreciation & amortization?
The current quarterly D&A of LAB is $3.86 M
What is the all time high quarterly D&A for Standard BioTools?
Standard BioTools all-time high quarterly depreciation & amortization is $5.19 M
What is Standard BioTools quarterly D&A year-on-year change?
Over the past year, LAB quarterly depreciation & amortization has changed by -$48.00 K (-1.23%)
What is Standard BioTools TTM depreciation & amortization?
The current TTM D&A of LAB is $16.81 M
What is the all time high TTM D&A for Standard BioTools?
Standard BioTools all-time high TTM depreciation & amortization is $18.78 M
What is Standard BioTools TTM D&A year-on-year change?
Over the past year, LAB TTM depreciation & amortization has changed by +$1.63 M (+10.76%)